UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer

Clinical cancer research, 2010-11, Vol.16 (21), p.5320-5328

2010

Volltextzugriff (PDF)

Cervical Cancer: Prevention, Diagnosis, and Therapeutics

CA: a cancer journal for clinicians, 2001-03, Vol.51 (2), p.92-114

2001

Volltextzugriff (PDF)

Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing

Journal of clinical oncology, 2018-12, Vol.36 (35), p.JCO1800328-3465

2018

Volltextzugriff (PDF)

Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer

Clinical cancer research, 2012-05, Vol.18 (9), p.2668-2678

2012

Volltextzugriff (PDF)

Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer

Gynecologic oncology, 2011-12, Vol.123 (3), p.479-485

2011

Volltextzugriff (PDF)

Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer

The Journal of supportive oncology, 2010-11, Vol.8 (6), p.252-258

2010

Volltextzugriff (PDF)

Invasive Endometrial Cancer in Uteri Resected for Atypical Endometrial Hyperplasia

Gynecologic oncology, 1994-03, Vol.52 (3), p.373-378

1994

Volltextzugriff (PDF)

The national cancer data base report on ovarian cancer

Cancer, 1995-09, Vol.76 (6), p.1096-1103

1995

Volltextzugriff (PDF)

Abstract P1-03-03: Experience in the community oncology practice with a 25-gene hereditary cancer panel

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P1-P1-03-03

2015

Volltextzugriff (PDF)

Overexpression of Tissue VEGF-A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer

Clinical cancer research, 2010-11, Vol.16 (21), p.5320-5328

2010

Volltextzugriff (PDF)

Epidemiology and biology of cervical cancer

Seminars in surgical oncology, 1999-04, Vol.16 (3), p.203-211

1999

Volltextzugriff (PDF)

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy

Clinical ovarian cancer and other gynecologic malignancies, 2009-11, Vol.2 (2), p.99-105

2009

Volltextzugriff (PDF)

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy

Clinical ovarian cancer and other gynecologic malignancies, 2009-09, Vol.2, p.10-16

2009

Volltextzugriff (PDF)

In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma

Gynecologic oncology, 1997, Vol.64 (1), p.18-25

1997

Volltextzugriff (PDF)

Generation of Tumor-Specific Cytotoxic T Lymphocytes by Stimulation with HPV Type 16 E7 Peptide-Pulsed Dendritic Cells: An Approach to Immunotherapy of Cervical Cancer

Gynecologic oncology, 1999-09, Vol.74 (3), p.448-455

1999

Volltextzugriff (PDF)

Combination Anti-Gene Therapy Targeting c- myc and p53 in Ovarian Cancer Cell Lines

Gynecologic oncology, 1995-10, Vol.59 (1), p.87-92

1995

Volltextzugriff (PDF)

p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines

Gynecologic oncology, 1997-07, Vol.66 (1), p.94-102

1997

Volltextzugriff (PDF)

In VitroAntigene Therapy Targeting HPV-16 E6 and E7 in Cervical Carcinoma

Gynecologic oncology, 1997-01, Vol.64 (1), p.18-25

1997

Volltextzugriff (PDF)

Critical care issues in cervical cancer management

Seminars in surgical oncology, 1999-04, Vol.16 (3), p.267-274

1999

Volltextzugriff (PDF)

Malondialdehyde precursors in gamma-irradiated DNA, deoxynucleotides and deoxynucleosides

Nucleic acids research, 1985-12, Vol.13 (24), p.9011-9029

1985

Volltextzugriff (PDF)

Tumor angiogenesis as a prognostic factor in ovarian carcinoma : Quantification of endothelial immunoreactivity by image analysis

Cancer, 1997-12, Vol.80 (12), p.2257-2262

1997

Volltextzugriff (PDF)

Significance of Intraperitoneal Cytology in Patients Undergoing Radical Hysterectomy

Gynecologic oncology, 1998-02, Vol.68 (2), p.169-171

1998

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer

Cervical Cancer: Prevention, Diagnosis, and Therapeutics

Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing

Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer

Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer

Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer

Invasive Endometrial Cancer in Uteri Resected for Atypical Endometrial Hyperplasia

The national cancer data base report on ovarian cancer

Abstract P1-03-03: Experience in the community oncology practice with a 25-gene hereditary cancer panel

Overexpression of Tissue VEGF-A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer

Epidemiology and biology of cervical cancer

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy

In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma

Generation of Tumor-Specific Cytotoxic T Lymphocytes by Stimulation with HPV Type 16 E7 Peptide-Pulsed Dendritic Cells: An Approach to Immunotherapy of Cervical Cancer

Combination Anti-Gene Therapy Targeting c- myc and p53 in Ovarian Cancer Cell Lines

p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines

In VitroAntigene Therapy Targeting HPV-16 E6 and E7 in Cervical Carcinoma

Critical care issues in cervical cancer management

Malondialdehyde precursors in gamma-irradiated DNA, deoxynucleotides and deoxynucleosides

Tumor angiogenesis as a prognostic factor in ovarian carcinoma : Quantification of endothelial immunoreactivity by image analysis

Significance of Intraperitoneal Cytology in Patients Undergoing Radical Hysterectomy

Suchergebnisse filtern